ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney"

  • 2020 American Transplant Congress

    Recipient and Donor Factors Associated with Post-Donation ESRD in Related White Living Kidney Donors

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, L. Cartwright1, D. Stewart1

    1Research, UNOS, Richmond, VA, 2Chief Medical Officer, UNOS, Richmond, VA

    *Purpose: We studied post-donation ESRD in white first-degree related living kidney donors (RLKDs) in the US between 1994 and 2018 (n=45700); this study is the…
  • 2020 American Transplant Congress

    Comparative Study between ATG and Grafalon as Induction Agent in Renal Transplant Recipient

    L. K. Das, P. Paudyal, S. Shrestha, B. Shahi, A. Pandey, R. Verma, P. Chandra Shrestha

    Kidney and Liver Transplant, Shahid Dharmabhakta National Transplant Center, Kathmandu, Nepal

    *Purpose: Renal transplantation (Rtx) remains the most effective treatment for of end-stage renal disease (ESRD). The development of induction therapy has significantly reduced the incidence…
  • 2020 American Transplant Congress

    Efficacy of Robotic-Assisted Bilateral Nephrectomy from a Single Approach

    G. Pan, M. Goodale, E. Martinez, G. Rofaiel

    Surgery, University of Utah, Salt Lake City, UT

    *Purpose: Bilateral native nephrectomies have been established as beneficial for ESRD (end-stage renal disease) patients with select indications in pre-transplant settings to avoid related complications.…
  • 2020 American Transplant Congress

    Risk Stratification in Antibody Incompatible Kidney Transplantation: Can Aggressive Rejection be Avoided?

    S. Punjala1, M. Ibrahim1, N. Vallant1, N. Kessaris1, O. Shaw2, N. Mamode1

    1Department of Nephrology, Renal Transplant and Urology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom, 2Clinical Transplantation Laboratory, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

    *Purpose: Our experience in antibody incompatible kidney transplantation, and anecdotal reports, suggest that a specific form of rejection, which we term Early Aggressive Antibody Mediated…
  • 2020 American Transplant Congress

    Re-Transplantation (Tx) in Pediatric Patients with Failure of Primary Transplant (Tx) Due to Recurrent Focal Segmental Glomerulosclerosis (FSGS). A Pediatric Nephrology Research Consortium (PNRC) Study

    A. Maniar1, D. Hooper2, C. Sethna1, P. Singer1, A. Z. Traum3, E. Kotzen4, K. Sanderson4, P. S. Verghese5, S. I. Al-Akash6

    1Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, NY, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Boston Children's Hospital, Boston, MA, 4University of North Carolina, Chapel Hill, NC, 5University of Minnesota Children's Hospital, Minneapolis, MN, 6Driscoll Children's Hospital, Corpus Christi, TX

    *Purpose: FSGS is a leading cause of end stage renal disease (ESRD). Tx in patients with FSGS may lead to graft failure due to recurrence…
  • 2020 American Transplant Congress

    Post-Transplant Rebound and Not Baseline Anti-A Titers are Associated with Acute Antibody-Mediated Rejection in A2– to B/O Incompatible Kidney Transplantation

    V. Kumar, D. Mompoint-Williams, M. Marques, P. MacLennan, M. Mustian, J. Locke

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Decreased antigen expression among blood group A subtype 2 (A2) donor kidneys allows these organs to be considered as universal donors; under the new…
  • 2020 American Transplant Congress

    Association with Acute Kidney Injury and Chronic Kidney Disease after Liver Transplantation

    R. Ide, M. Ohira, H. Ohdan

    Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan

    *Purpose: Although early survival after liver transplantation (LT) has improved, late complications such as renal dysfunction have been discussed as a problem. Here, we have…
  • 2020 American Transplant Congress

    Introduction of Preemptive Pharmacogenomic Testing in Kidney Transplant Recipients: Early Evaluation of the Clinical Impact of Genomic Guided Tacrolimus Dosing

    G. Girone1, V. Do1, K. Belfield1, R. Pulk1, E. Cohen1, E. Marin2

    1Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, 2Department of Nephrology, Yale School of Medicine, New Haven, CT

    *Purpose: Tacrolimus is widely accepted as the mainstay of immunosuppression in solid organ transplant. Inherited differences in CYP3A activity are known to contribute to dosing…
  • 2020 American Transplant Congress

    Associations of Chronic Kidney Disease with Temperature, Ancestry and Employment

    A. A. Connor, B. I. Shaw, K. V. Ravindra

    Surgery, Duke University, Durham, NC

    *Purpose: We sought to assess the suggested associations of chronic kidney disease (CKD) of unknown origin, also known as Mesoamerican Nephropathy, with temperature, ancestry and…
  • 2020 American Transplant Congress

    Hemodialysis (HD) Treatment Associates with Increased Risk of Delayed Graft Function (DGF) after Renal Transplantation (RT) and Augmented Cd4 and Cd8 T Cell Proliferation Compared to Peritoneal Dialysis (PD)

    A. Angeletti1, C. Donadei1, G. Donati1, G. Di Certo1, D. Conte1, L. Gasperoni1, E. Pelizzaro1, C. Guglielmo1, G. Comai1, P. Cravedi2, G. La Manna1

    1DIMES, S.Orsola-Malpighi Hospital, Bologna University, Bologna, Italy, 2DIMES, Icahn School of Medicine at Mount Sinai, New York, NY, US, New York, NY

    *Purpose: Delayed graft function (DGF) is a common event after RT that increases the risk of acute rejection and early graft loss. The impact of…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 101
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences